The CD274 gene encodes an immunosuppressive receptor ligand expressed by hematopoietic and non hematopoietic cells, such as T cells and B cells, as well as various types of tumor cells. The encoded protein is a type I transmembrane protein with immunoglobulin V-like and C-like domains. The interaction between this ligand and its receptor inhibits T cell activation and cytokine production.
Our expert team focuses on optimizing expression systems and refining purification strategies to ensure the high quality of our biosimilar antibodies.